Rivaroxaban crystal form IV substance, preparation method and composition thereof, and uses of rivaroxaban crystal form IV substance and composition

Rivaroxaban crystal form IV substance, preparation method and composition thereof, and uses of rivaroxaban crystal form IV substance and composition

  • CN 105,367,563 A
  • Filed: 08/20/2014
  • Published: 03/02/2016
  • Est. Priority Date: 08/20/2014
  • Status: Active Application
First Claim
Patent Images

1. razaxaban brilliant IV type solid matter, is characterized in that, when use powder x-ray diffraction analysis adopts CuK α

  • during radiation experiments condition, diffraction peak position 2-Theta value (°

    ) or d value diffraction peak relative intensity peak height value (Height%) or peak area value (Area%) have following expression;

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×